Automate Your Wheel Strategy on BTMD
With Tiblio's Option Bot, you can configure your own wheel strategy including BTMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BTMD
- Rev/Share 6.3086
- Book/Share -2.4984
- PB -1.2768
- Debt/Equity -1.3685
- CurrentRatio 0.9796
- ROIC 0.5405
- MktCap 141209660.0
- FreeCF/Share 1.1086
- PFCF 4.0364
- PE 3.2153
- Debt/Assets 1.0295
- DivYield 0
- ROE -0.3119
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 3
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BTMD | B. Riley Securities | Buy | Neutral | -- | $4 | Aug. 7, 2025 |
| Initiation | BTMD | Craig Hallum | -- | Buy | -- | -- | Dec. 16, 2024 |
News
Restructuring At Biote Will Drive Greater Growth And Profitability
Published: September 10, 2025 by: Seeking Alpha
Sentiment: Positive
I maintain my Strong Buy rating on biote Corp. due to its promising growth prospects, despite ongoing restructuring and short-term earnings pressure. The company's vertical integration, digital platform growth, and improved cost controls are driving margin expansion and long-term profitability potential. Restructuring aims to accelerate provider wins, deepen practitioner relationships, and boost financial discipline, though it has led to lower 2025 guidance.
Read More
Is biote Corp. (BTMD) Stock Undervalued Right Now?
Published: July 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Biote Corp. (BTMD) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.23 per share a year ago.
Read More
About biote Corp. (BTMD)
- IPO Date 2021-04-28
- Website https://biote.com
- Industry Medical - Care Facilities
- CEO Bret Christensen
- Employees 217